News from Japan
From President Beverley Yamamoto, HAE Japan We have seen great improvement in the treatment environment in Japan over the last two years, and in September the third long term prophylactic treatment was approved by the PMDA. Since last reporting to Global Perspectives, we have also seen the indications for use of Icatibant expanded to [...]